AEGiS-Reuters: Laboratory to unveil 2 HIV diagnostic tests

Reuters, Ltd.Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu






DonateNow


Laboratory to unveil 2 HIV diagnostic tests

Reuters NewMedia, Inc.; Tuesday June 30, 9:36 am EST


NEW YORK, June 30 (Reuters) - Laboratory Corp. of America Holdings and VIRCO, a private Belgian biotechnology company, on Tuesday said their two new diagnostic tests for HIV, Antivirogram and VircoGEN, will be available in the U.S. for commercial use on July 20.

The testing procedures will enable physicians to evaluate resistance of HIV to antiretroviral drugs, the companies said, helping them to make decisions on which medications are most likely to be effective against the HIV virus.

In studies using Antivirogram and VircoGEN, physicians were able to predict antiviral response in antiretroviral- experienced patients, the companies said. Laboratory Corp. of America Holding is a national clinical laboratory organization, which operates primary testing facilities nationally.

VIRCO specializes in genomics and bioinformatics applied to disease management.


980630
RE980618


Copyright © 1998 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .